Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      FDA rejects Agiles contraceptive patch

      FDA rejects Agile's contraceptive patch

      Ruby Khatun Khatun26 Dec 2017 9:15 AM IST
      Agile Therapeutics Inc said the U.S. Food and Drug Administration declined to approve its contraceptive patch for the second time, sending the drug...
      NPPA eases norms for new drug approvals

      NPPA eases norms for new drug approvals

      Ruby Khatun Khatun25 Dec 2017 10:56 AM IST
      Through a recent notification, National Pharmaceutical Pricing Authority (NPPA), Department of Pharmaceuticals, Ministry of Chemical and Fetilizers,...
      India fast emerging as inventors hub for drugs patent

      India fast emerging as inventors hub for drugs patent

      Ruby Khatun Khatun25 Dec 2017 10:30 AM IST
      Chandigarh: India is fast emerging as an inventors' hub for patents for an assortment of drugs worldwide. Around 15 percent of the total 1.3 lakh...
      FDA clears stereotactic radiotherapy system for use in treating breast cancer

      FDA clears stereotactic radiotherapy system for use in treating breast cancer

      Ruby Khatun Khatun25 Dec 2017 10:18 AM IST
      The U.S. Food and Drug Administration (FDA) cleared a new noninvasive stereotactic radiotherapy system intended for use in treating cancer in breast...
      Roche scores cancer drug approvals in Europe and US

      Roche scores cancer drug approvals in Europe and US

      Ruby Khatun Khatun25 Dec 2017 10:15 AM IST
      ZURICH: Swiss drugmaker Roche has won fresh approvals for two cancer drugs in Europe and the United States, shoring up its position in new medicines...
      US judge tosses verdict against AbbVie in AndroGel case

      US judge tosses verdict against AbbVie in AndroGel case

      Ruby Khatun Khatun25 Dec 2017 10:00 AM IST
      A U.S. judge on Friday overturned a $150 million verdict against AbbVie Inc that was the first to result from lawsuits claiming that the company...
      United Therapeutics to pay 210 million dollars to resolve US kickback probe

      United Therapeutics to pay 210 million dollars to resolve US kickback probe

      Ruby Khatun Khatun25 Dec 2017 9:45 AM IST
      BOSTON: United Therapeutics Corp will pay $210 million to resolve U.S. claims that the drugmaker used a charity as a conduit to illegally cover...
      California court says Novartis can be sued over generic drug injuries

      California court says Novartis can be sued over generic drug injuries

      Ruby Khatun Khatun25 Dec 2017 9:30 AM IST
      California’s top court opened the door for consumers to sue Novartis AG and other makers of brand-name pharmaceutical products over injuries blamed on...
      Liberate pharmacy education from dual control: Pharmaceutical Congress

      Liberate pharmacy education from dual control: Pharmaceutical Congress

      Ruby Khatun Khatun25 Dec 2017 9:15 AM IST
      Chandigarh: Arguing that pharmacy education courses are not technical programmes, the 69th Indian Pharmaceutical Congress (IPC) on Sunday passed a...
      FDA approves drug to treat dangerously low blood pressure

      FDA approves drug to treat dangerously low blood pressure

      Ruby Khatun Khatun24 Dec 2017 10:45 AM IST
      The U.S. Food and Drug Administration (FDA) approved Giapreza (angiotensin II) injection for intravenous infusion to increase blood pressure in adults...
      Roche to buy US cancer drugmaker Ignyta for 1.7 billion dollars

      Roche to buy US cancer drugmaker Ignyta for 1.7 billion dollars

      Ruby Khatun Khatun24 Dec 2017 10:30 AM IST
      Swiss drugmaker Roche will buy U.S. cancer drug specialist Ignyta Inc for $1.7 billion in an agreed deal to broaden its oncology portfolio, the firms...
      USFDA approves new diabetes drug from Merck and Pfizer

      USFDA approves new diabetes drug from Merck and Pfizer

      Ruby Khatun Khatun24 Dec 2017 10:15 AM IST
      A new drug developed by Merck & Co and Pfizer Inc won U.S. approval to treat type II diabetes, the Food and Drug Administration said, adding...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok